Sharlene Adams Selected Research

talabostat

8/2004	PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
9/2003	Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharlene Adams Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 08/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2004
1	Melanoma (Melanoma, Malignant) 08/2004
1	Fibrosarcoma 08/2004
1	Carcinoma (Carcinomatosis) 08/2004
1	Mastocytoma 08/2004
1	Lymphoma (Lymphomas) 08/2004
1	Anemia 09/2003
1	Neutropenia 09/2003

Drug/Important Bio-Agent (IBA)

2	Insulin-Like PeptidesIBA 01/2018 - 02/2014
2	Trastuzumab (Herceptin)FDA Link 03/2012 - 08/2004
2	talabostatIBA 08/2004 - 09/2003
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Differentiation AntigensIBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	IstiratumabIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2014
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2014
1	MM-111IBA 03/2012
1	Complement System Proteins (Complement)IBA 03/2012
1	Lapatinib (GW572016)FDA Link 03/2012
1	LigandsIBA 03/2012
1	CytokinesIBA 08/2004
1	Proteins (Proteins, Gene)FDA Link 08/2004
1	Rituximab (Mabthera)FDA Link 08/2004
1	ChemokinesIBA 08/2004
1	PT-100 dipeptideIBA 09/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
2	Therapeutics 01/2018 - 03/2012
1	Oral Administration 08/2004